Skip to main content
Erschienen in: Der Urologe 1/2017

23.11.2016 | Antibiotika | Evidenzbasierte Medizin

Antibiotische Prophylaxe für transrektale Prostatastanzbiopsien

verfasst von: Dr. L. Schneidewind

Erschienen in: Die Urologie | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Auszug

Zani EL, Clark OAC, Rodriges Netto Jr N (2011) Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev (5):CD006576. doi: 10.​1002/​14651858.​CD006576.​pub2
Literatur
1.
2.
Zurück zum Zitat Wagenlehner FME, van Ostrum E, Tenke P, Tandogdu Z, Cek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE (2013) Infective complications after prostate biopsy: outcome of the global prevalence study of infections in urology (GPUI) 2010 and 2011, a prospective multinational Multicentre prostate biopsy study. Eur Urol 63:521–527CrossRefPubMed Wagenlehner FME, van Ostrum E, Tenke P, Tandogdu Z, Cek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE (2013) Infective complications after prostate biopsy: outcome of the global prevalence study of infections in urology (GPUI) 2010 and 2011, a prospective multinational Multicentre prostate biopsy study. Eur Urol 63:521–527CrossRefPubMed
3.
Zurück zum Zitat Robert Koch Institut: Epidemiologisches Bulletin 27.Juni 2016/Nr. 25 – Bericht des Nationalen Referenzzentrums (NRZ) für gramnegative Krankenhauserreger – Zeitraum 1. Januar 2015 bis 31. Dezember 2015 Robert Koch Institut: Epidemiologisches Bulletin 27.Juni 2016/Nr. 25 – Bericht des Nationalen Referenzzentrums (NRZ) für gramnegative Krankenhauserreger – Zeitraum 1. Januar 2015 bis 31. Dezember 2015
4.
Zurück zum Zitat Cai T, Gallelli L, Cocci A, Tiscione D, Verze P, Lanciotti M, Vanacore D, Rizzo M, Gacci M, Saleh O, Malossini G, Liguori G, Trombetta C, Rocco D, Palmieri A, Bartoletti R, Carini M, Wagenlehner FME, Naber K, Mirone V, Bjerklund-Johanson TE (2016) Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative. World J Urol. doi:10.1007/s00345-016-1867-6 Cai T, Gallelli L, Cocci A, Tiscione D, Verze P, Lanciotti M, Vanacore D, Rizzo M, Gacci M, Saleh O, Malossini G, Liguori G, Trombetta C, Rocco D, Palmieri A, Bartoletti R, Carini M, Wagenlehner FME, Naber K, Mirone V, Bjerklund-Johanson TE (2016) Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative. World J Urol. doi:10.​1007/​s00345-016-1867-6
5.
Zurück zum Zitat Agbugui JO, Obarisiagon EO, Osaigbovo EO, Osime CO, Akumbar PN (2014) Antibiotic prophylaxis for transrectal prostate biopsy: a comparison of one-day and five-day regimen. Niger Postgrad Med J 21:213–217PubMed Agbugui JO, Obarisiagon EO, Osaigbovo EO, Osime CO, Akumbar PN (2014) Antibiotic prophylaxis for transrectal prostate biopsy: a comparison of one-day and five-day regimen. Niger Postgrad Med J 21:213–217PubMed
6.
Zurück zum Zitat Bateni ZH, Hossein S, Salimi H, Safari H, Tabatabei M, Saedi D (2014) Single-dose versus multi-dose ciprofloxacin plus Metronidazole prophylaxis in transrectal ultrasound-guided biopsy of the prostate: a randomized controlled trial. Acta Med Iran 52:664–670 Bateni ZH, Hossein S, Salimi H, Safari H, Tabatabei M, Saedi D (2014) Single-dose versus multi-dose ciprofloxacin plus Metronidazole prophylaxis in transrectal ultrasound-guided biopsy of the prostate: a randomized controlled trial. Acta Med Iran 52:664–670
7.
Zurück zum Zitat AbuGosh Z, Margolik J, Goldenberg SL, Teylor SA, Afshar K, Bell R, Lange D, Bowie WR, Roscoe D, Machan L, Black PC (2013) A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol 189:1326–1331CrossRef AbuGosh Z, Margolik J, Goldenberg SL, Teylor SA, Afshar K, Bell R, Lange D, Bowie WR, Roscoe D, Machan L, Black PC (2013) A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol 189:1326–1331CrossRef
8.
Zurück zum Zitat Chan ES, Lo KL, Ng CF, Hou SM, Yip SK (2012) Randomized controlled trial of antibiotic prophylaxis regimen for transrectal ultrasound-guided prostate biopsy. Chin Med J 125(14):2432–2435PubMed Chan ES, Lo KL, Ng CF, Hou SM, Yip SK (2012) Randomized controlled trial of antibiotic prophylaxis regimen for transrectal ultrasound-guided prostate biopsy. Chin Med J 125(14):2432–2435PubMed
9.
Zurück zum Zitat Sen V, Ayodogdu O, Bozkurt IH, Yonguc T, Sen P, Polat S, Degirmenci T, Bolat D (2015) The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: A prospective, randomized, and controlled clinical study. Can Urol Assoc J 9:863–867CrossRef Sen V, Ayodogdu O, Bozkurt IH, Yonguc T, Sen P, Polat S, Degirmenci T, Bolat D (2015) The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: A prospective, randomized, and controlled clinical study. Can Urol Assoc J 9:863–867CrossRef
10.
Zurück zum Zitat Qiao LD, Chen S, Wang XF, Yang WM, Niu YJ, Kong CZ, Tang W, Gao XF, Shi BK, Na YQ, Zhang XD, Wang JY, Zhang Y, Chen Z (2016) A multi-center, controlled, randomized, open-label clinical study of levofloxacin for preventing infection during perioperative period of ultrasound-guided transrectal prostate biopsy. Eur J Clin Microbiol Infect Dis. doi:10.1007/s10096-016-2742-5 PubMedPubMedCentral Qiao LD, Chen S, Wang XF, Yang WM, Niu YJ, Kong CZ, Tang W, Gao XF, Shi BK, Na YQ, Zhang XD, Wang JY, Zhang Y, Chen Z (2016) A multi-center, controlled, randomized, open-label clinical study of levofloxacin for preventing infection during perioperative period of ultrasound-guided transrectal prostate biopsy. Eur J Clin Microbiol Infect Dis. doi:10.​1007/​s10096-016-2742-5 PubMedPubMedCentral
11.
Zurück zum Zitat Miyazaki Y, Akamatsu S, Kanamaru S, Kamiyama Y, Sengiku A, Iguchi R, Sano T, Takahashi A, Ito M, Takenawa J, Ito N, Ogura K (2016) A prospective randomized trial comparing a combined regimen of amakin and levofloxacin to levofloxacin alone as prophylaxis in transrectal prostate needle bopsy. Urol Oncol 13:2533–2540 Miyazaki Y, Akamatsu S, Kanamaru S, Kamiyama Y, Sengiku A, Iguchi R, Sano T, Takahashi A, Ito M, Takenawa J, Ito N, Ogura K (2016) A prospective randomized trial comparing a combined regimen of amakin and levofloxacin to levofloxacin alone as prophylaxis in transrectal prostate needle bopsy. Urol Oncol 13:2533–2540
12.
Zurück zum Zitat Samarinas M, Dimitropoulos K, Zachos I, Gravas S, Karatzas A, Tzortzis V (2016) A single dose of meropenem is superior to ciprofloxacin in preventing infections after trabsrectal ultrasound-guided prostate biopsies in the era of quinolone resistance. World J Urol. doi:10.1007/s00345-016-180-z PubMed Samarinas M, Dimitropoulos K, Zachos I, Gravas S, Karatzas A, Tzortzis V (2016) A single dose of meropenem is superior to ciprofloxacin in preventing infections after trabsrectal ultrasound-guided prostate biopsies in the era of quinolone resistance. World J Urol. doi:10.​1007/​s00345-016-180-z PubMed
13.
Zurück zum Zitat Schneidewind L, Kranz J, Boehm K, Spachmann P, Siegel F, Huck N, Fritsche HM (2016) Antibiotic stewardship (ABS). Definition, contents, necessity and practice on examples of current clinical urological controversies. Urologe A 55:489–493CrossRefPubMed Schneidewind L, Kranz J, Boehm K, Spachmann P, Siegel F, Huck N, Fritsche HM (2016) Antibiotic stewardship (ABS). Definition, contents, necessity and practice on examples of current clinical urological controversies. Urologe A 55:489–493CrossRefPubMed
14.
Zurück zum Zitat Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schröder FH, Roobol MJ (2012) Infectious complications and hospital admissions after prostate biopsy in a european randomized trial. Eur Urol 61:1110–1114CrossRefPubMed Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schröder FH, Roobol MJ (2012) Infectious complications and hospital admissions after prostate biopsy in a european randomized trial. Eur Urol 61:1110–1114CrossRefPubMed
15.
Zurück zum Zitat Wagenlehner FME (2014) Editorial comment from Dr. Wagenlehner to hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: a database analysis in England. Int J Urol. doi:10.1111/iju.12646 Wagenlehner FME (2014) Editorial comment from Dr. Wagenlehner to hospital admissions after transrectal ultrasound-guided biopsy of the prostate in men diagnosed with prostate cancer: a database analysis in England. Int J Urol. doi:10.​1111/​iju.​12646
16.
Zurück zum Zitat Cussans A, Somani BK, Basarab A, Dudderidge TJ (2016) The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review. BJU Int 117:725–731CrossRefPubMed Cussans A, Somani BK, Basarab A, Dudderidge TJ (2016) The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review. BJU Int 117:725–731CrossRefPubMed
17.
Zurück zum Zitat Liss MA, Nakamura KK, Mauleners R, Kolla SB, Dash A, Peterson EM (2013) Screening rectal culture to identify fluorchinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate? Urology 82:67–73CrossRefPubMedPubMedCentral Liss MA, Nakamura KK, Mauleners R, Kolla SB, Dash A, Peterson EM (2013) Screening rectal culture to identify fluorchinolone-resistant organisms before transrectal prostate biopsy: do the culture results between office visit and biopsy correlate? Urology 82:67–73CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat van Besien J, Uvin P, van den Abeele AM, Merckx L (2016) Prevalence, risk factors, and clinical relevance of fluorchinolone-resistant organisms in rectal cultures: should we target antibiotic prophylaxis prior to prostate biopsy? Adv Urol. doi:10.1155/2016/5392107 PubMedPubMedCentral van Besien J, Uvin P, van den Abeele AM, Merckx L (2016) Prevalence, risk factors, and clinical relevance of fluorchinolone-resistant organisms in rectal cultures: should we target antibiotic prophylaxis prior to prostate biopsy? Adv Urol. doi:10.​1155/​2016/​5392107 PubMedPubMedCentral
19.
Zurück zum Zitat Tsivian M, Abern MR, Qi P, Polascik TJ (2013) Short-term functional outcome and complications associated with transperineal template prostate mapping biopsy. Urology 82:166–170CrossRefPubMed Tsivian M, Abern MR, Qi P, Polascik TJ (2013) Short-term functional outcome and complications associated with transperineal template prostate mapping biopsy. Urology 82:166–170CrossRefPubMed
20.
Zurück zum Zitat Yang L, Gao L, Chen Y, Tang Z, Liu L, Han P, Zeng H, Li X, Wei Q (2015) Prophylactic antibiotics in prostate biopsy: a meta-analysis based on randomized controlled trials. Surg Infect 16:733–747CrossRef Yang L, Gao L, Chen Y, Tang Z, Liu L, Han P, Zeng H, Li X, Wei Q (2015) Prophylactic antibiotics in prostate biopsy: a meta-analysis based on randomized controlled trials. Surg Infect 16:733–747CrossRef
21.
Zurück zum Zitat Cai T, Verze P, Brugnolli A, Tiscione D, Lucianni LG, Eccher C, Lanzafane P, Malossini G, Wagenlehner FME, Mirone V, Bjerklund-Johansen TE, Pickard R, Bartoletti R (2016) Adherence to European association of urology guidelines on prophylactic antibiotics: an important step in antimicrobial stewardship. Eur Urol 69:276–283CrossRefPubMed Cai T, Verze P, Brugnolli A, Tiscione D, Lucianni LG, Eccher C, Lanzafane P, Malossini G, Wagenlehner FME, Mirone V, Bjerklund-Johansen TE, Pickard R, Bartoletti R (2016) Adherence to European association of urology guidelines on prophylactic antibiotics: an important step in antimicrobial stewardship. Eur Urol 69:276–283CrossRefPubMed
22.
Zurück zum Zitat Iarikov D, Wassel R, Farley J, Nambiar S (2015) Adverse events associated with fosfomycin use: review of the literature and analyses of the FDA adverse event reporting system database. Infect Dis Ther 4:433–458CrossRefPubMedPubMedCentral Iarikov D, Wassel R, Farley J, Nambiar S (2015) Adverse events associated with fosfomycin use: review of the literature and analyses of the FDA adverse event reporting system database. Infect Dis Ther 4:433–458CrossRefPubMedPubMedCentral
Metadaten
Titel
Antibiotische Prophylaxe für transrektale Prostatastanzbiopsien
verfasst von
Dr. L. Schneidewind
Publikationsdatum
23.11.2016
Verlag
Springer Medizin
Erschienen in
Die Urologie / Ausgabe 1/2017
Print ISSN: 2731-7064
Elektronische ISSN: 2731-7072
DOI
https://doi.org/10.1007/s00120-016-0283-2

Weitere Artikel der Ausgabe 1/2017

Der Urologe 1/2017 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.